# Disc Medicine (IRON) — News

IRON · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/iron/news

## Recent headlines

- [Japan's Ormon to buy Onlogic for around 100B yen: Nikkei](https://www.ainvest.com/news/japan-ormon-buy-onlogic-100b-yen-nikkei-2610) — AInvest Wire, Oct 12, 2026
  Japan's Ormon has agreed to acquire Onlogic for approximately 100 billion yen, according to reports from Nikkei. The deal is expected to significantly expand Ormon's operations and strengthen its market position. The acquisition aligns with Ormon's broader strategy to enhance technological…
- [Penn Medicine, IBA start V to advance proton therapy](https://www.ainvest.com/news/penn-medicine-iba-start-advance-proton-therapy-2609) — AInvest Wire, Sep 28, 2026
  Penn Medicine and IBA, a Belgian manufacturer of proton therapy systems, have initiated a collaboration to advance proton therapy capabilities in the United States. As part of this partnership, IBA will supply two Proteus®ONE proton therapy systems for Penn Medicine’s new Roberts Proton Therapy…
- [Disc Medicine, Inc.: Wells Fargo raises target price to $86 from $79](https://www.ainvest.com/news/disc-medicine-wells-fargo-raises-target-price-86-79-2609) — AInvest Wire, Sep 16, 2026
  Wells Fargo has adjusted its price target for Disc Medicine, Inc. (IRON.US), raising it to $86 from $79, while maintaining its "Buy" rating for the stock. The updated target reflects the firm’s ongoing confidence in the company’s strategic direction and operational performance. The move comes amid…
- [Disc Medicine, Inc.: Wedbush raises target price to $100 from $88](https://www.ainvest.com/news/disc-medicine-wedbush-raises-target-price-100-88-2609) — AInvest Wire, Sep 2, 2026
- [Disc Medicine - ends Q2 2026 with $717.70 mln in cash and securities; runway into 2029](https://www.ainvest.com/news/disc-medicine-ends-q2-2026-717-70-mln-cash-securities-runway-2029-2607) — AInvest Wire, Jul 30, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).